These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11139133)

  • 1. The human CYP3A subfamily: practical considerations.
    Wrighton SA; Schuetz EG; Thummel KE; Shen DD; Korzekwa KR; Watkins PB
    Drug Metab Rev; 2000; 32(3-4):339-61. PubMed ID: 11139133
    [No Abstract]   [Full Text] [Related]  

  • 2. Update: clinically significant cytochrome P-450 drug interactions.
    Michalets EL
    Pharmacotherapy; 1998; 18(1):84-112. PubMed ID: 9469685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic xenosensors: humanizing mice.
    Gillam E
    Trends Pharmacol Sci; 2000 Sep; 21(9):330-1. PubMed ID: 10973081
    [No Abstract]   [Full Text] [Related]  

  • 4. Contraceptive effectiveness: cytochromes and induction.
    Shader RI; Oesterheld JR
    J Clin Psychopharmacol; 2000 Apr; 20(2):119-21. PubMed ID: 10770447
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of CYP3A enzymes in human and rat hepatocyte cultures.
    Williams JA; Chenery RJ; Hawksworth GM
    Biochem Soc Trans; 1994 May; 22(2):131S. PubMed ID: 7958202
    [No Abstract]   [Full Text] [Related]  

  • 6. Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interactions with 17 alpha-ethynylestradiol.
    Olsen AK; Hansen KT; Friis C
    Chem Biol Interact; 1997 Nov; 107(1-2):93-108. PubMed ID: 9402952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort.
    Bolley R; Zülke C; Kammerl M; Fischereder M; Krämer BK
    Transplantation; 2002 Mar; 73(6):1009. PubMed ID: 11923712
    [No Abstract]   [Full Text] [Related]  

  • 8. CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies.
    Engman HA; Lennernäs H; Taipalensuu J; Otter C; Leidvik B; Artursson P
    J Pharm Sci; 2001 Nov; 90(11):1736-51. PubMed ID: 11745731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.
    Lacroix D; Sonnier M; Moncion A; Cheron G; Cresteil T
    Eur J Biochem; 1997 Jul; 247(2):625-34. PubMed ID: 9266706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.
    Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K
    Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alprazolam is another substrate for human cytochrome P450-3A isoforms.
    Venkatakrishnan K; Greenblatt DJ; von Moltke LL; Shader RI
    J Clin Psychopharmacol; 1998 Jun; 18(3):256. PubMed ID: 9617989
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment on Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients.
    Merry C
    AIDS; 2001 May; 15(8):1057-8. PubMed ID: 11399989
    [No Abstract]   [Full Text] [Related]  

  • 13. Consultation-liaison psychiatry drug--drug interactions update.
    Armstrong SC; Cozza KL; Cole MA
    Psychosomatics; 2000; 41(4):375-6. PubMed ID: 10906369
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.
    Gibbs MA; Thummel KE; Shen DD; Kunze KL
    Drug Metab Dispos; 1999 Feb; 27(2):180-7. PubMed ID: 9929500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
    Buters JT; Korzekwa KR; Kunze KL; Omata Y; Hardwick JP; Gonzalez FJ
    Drug Metab Dispos; 1994; 22(5):688-92. PubMed ID: 7835218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone withdrawal when starting an antiretroviral regimen including nevirapine.
    Heelon MW; Meade LB
    Pharmacotherapy; 1999 Apr; 19(4):471-2. PubMed ID: 10212021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes.
    Madan A; Graham RA; Carroll KM; Mudra DR; Burton LA; Krueger LA; Downey AD; Czerwinski M; Forster J; Ribadeneira MD; Gan LS; LeCluyse EL; Zech K; Robertson P; Koch P; Antonian L; Wagner G; Yu L; Parkinson A
    Drug Metab Dispos; 2003 Apr; 31(4):421-31. PubMed ID: 12642468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.
    Wang E; Lew K; Barecki M; Casciano CN; Clement RP; Johnson WW
    Chem Res Toxicol; 2001 Dec; 14(12):1596-603. PubMed ID: 11743742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of fibric acid derivatives.
    Spence JD
    Clin Pharmacokinet; 1998 May; 34(5):419-20. PubMed ID: 9592623
    [No Abstract]   [Full Text] [Related]  

  • 20. Bimodal distribution of renal cytochrome P450 3A activity in humans.
    Haehner BD; Gorski JC; Vandenbranden M; Wrighton SA; Janardan SK; Watkins PB; Hall SD
    Mol Pharmacol; 1996 Jul; 50(1):52-9. PubMed ID: 8700118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.